{"transactions":[{"id":4630611,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-10-05T21:00:49.000Z","date":"2026-10-02","kind":"exercise","planned":false,"acquired":false,"shares":27,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of October 2, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-10-02","underlying":"Common Stock","underlying_shares":27},"source":{"system":"sec-edgar","filing":"0000875045-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2057736/000087504526000084/form4.xml","form_type":"4"}},{"id":4630610,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-10-05T21:00:49.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of October 1, 2026."}],"balance_after":985,"derivative":{"exercise_price":0,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":985},"source":{"system":"sec-edgar","filing":"0000875045-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2057736/000087504526000084/form4.xml","form_type":"4"}},{"id":4630609,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-05T21:00:49.000Z","date":"2026-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":8,"price":219.88,"value":1759.04,"ownership":{"direct":true},"balance_after":1458.9845,"source":{"system":"sec-edgar","filing":"0000875045-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2057736/000087504526000084/form4.xml","form_type":"4"}},{"id":4630608,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-05T21:00:49.000Z","date":"2026-10-02","kind":"exercise","planned":false,"acquired":true,"shares":27,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 98.3178 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2026, 6/30/2026, and 9/30/2026."}],"balance_after":1466.9845,"source":{"system":"sec-edgar","filing":"0000875045-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057736/000087504526000084/form4.xml","form_type":"4"}},{"id":2164,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-03T20:14:24.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":7405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of September 1, 2026."}],"balance_after":7405,"derivative":{"exercise_price":0,"expiration_date":"2029-09-01","underlying":"Common Stock","underlying_shares":7405},"source":{"system":"sec-edgar","filing":"0000875045-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661567/000087504526000082/form4.xml","form_type":"4"}},{"id":696340,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":23440,"kind":"person","name":"Minor Lloyd","position":1,"cik":"0002038687","reported_name":"Minor Lloyd","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-05T20:03:20.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":593,"price":200.96,"value":119169.28,"ownership":{"direct":true},"balance_after":2689,"source":{"system":"sec-edgar","filing":"0000875045-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000076/form4.xml","form_type":"4"}},{"id":696339,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":23440,"kind":"person","name":"Minor Lloyd","position":1,"cik":"0002038687","reported_name":"Minor Lloyd","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-05T20:03:20.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":593,"price":203.34,"value":120580.62,"ownership":{"direct":true},"balance_after":3282,"source":{"system":"sec-edgar","filing":"0000875045-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000076/form4.xml","form_type":"4"}},{"id":742301,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":38935,"kind":"person","name":"HAWKINS WILLIAM A","position":1,"cik":"0001106508","reported_name":"HAWKINS WILLIAM A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:50:34.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":10365,"source":{"system":"sec-edgar","filing":"0000875045-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000065/form4.xml","form_type":"4"}},{"id":742300,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:47:54.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":15193,"source":{"system":"sec-edgar","filing":"0000875045-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000064/form4.xml","form_type":"4"}},{"id":742299,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39449,"kind":"person","name":"Rowinsky Eric K","position":1,"cik":"0001318886","reported_name":"Rowinsky Eric K","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:46:22.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":25844,"source":{"system":"sec-edgar","filing":"0000875045-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000063/form4.xml","form_type":"4"}},{"id":742298,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39448,"kind":"person","name":"Mantas Jesus B","position":1,"cik":"0001777331","reported_name":"Mantas Jesus B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:44:45.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":11263,"source":{"system":"sec-edgar","filing":"0000875045-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000062/form4.xml","form_type":"4"}},{"id":742297,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39447,"kind":"person","name":"LANGER SUSAN","position":1,"cik":"0001982640","reported_name":"LANGER SUSAN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:34:50.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":6634.1,"source":{"system":"sec-edgar","filing":"0000875045-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000060/form4.xml","form_type":"4"}},{"id":742296,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":26501,"kind":"person","name":"Patolawala Monish D","position":1,"cik":"0001815253","reported_name":"Patolawala Monish D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:32:31.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":5215,"source":{"system":"sec-edgar","filing":"0000875045-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000059/form4.xml","form_type":"4"}},{"id":742295,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39446,"kind":"person","name":"Pangalos Menelas N","position":1,"cik":"0002001873","reported_name":"Pangalos Menelas N","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T21:21:32.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":2370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-06-17","underlying":"Common Stock","underlying_shares":2370},"source":{"system":"sec-edgar","filing":"0000875045-26-000055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000055/form4.xml","form_type":"4"}},{"id":742294,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39446,"kind":"person","name":"Pangalos Menelas N","position":1,"cik":"0002001873","reported_name":"Pangalos Menelas N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:21:32.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000875045-26-000055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000055/form4.xml","form_type":"4"}},{"id":742293,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39446,"kind":"person","name":"Pangalos Menelas N","position":1,"cik":"0002001873","reported_name":"Pangalos Menelas N","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:21:32.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":2370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2370,"source":{"system":"sec-edgar","filing":"0000875045-26-000055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000055/form4.xml","form_type":"4"}},{"id":742292,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":23440,"kind":"person","name":"Minor Lloyd","position":1,"cik":"0002038687","reported_name":"Minor Lloyd","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:17:18.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":3875,"source":{"system":"sec-edgar","filing":"0000875045-26-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000054/form4.xml","form_type":"4"}},{"id":742291,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":39445,"kind":"person","name":"Freire Maria C","position":1,"cik":"0001547999","reported_name":"Freire Maria C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:09:24.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":2005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":8820,"source":{"system":"sec-edgar","filing":"0000875045-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000052/form4.xml","form_type":"4"}},{"id":792834,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2026-05-05T20:11:57.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of May 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-05-01","underlying":"Common Stock","underlying_shares":939},"source":{"system":"sec-edgar","filing":"0000875045-26-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000046/form4.xml","form_type":"4"}},{"id":792833,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2026-05-05T20:11:57.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":455,"price":187.06,"value":85112.3,"ownership":{"direct":true},"balance_after":6365,"source":{"system":"sec-edgar","filing":"0000875045-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000046/form4.xml","form_type":"4"}},{"id":792832,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2026-05-05T20:11:57.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":939,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6820,"source":{"system":"sec-edgar","filing":"0000875045-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000046/form4.xml","form_type":"4"}},{"id":817894,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-04-03T20:05:27.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of April 1, 2025."}],"balance_after":364,"derivative":{"exercise_price":0,"expiration_date":"2028-04-01","underlying":"Common Stock","underlying_shares":181},"source":{"system":"sec-edgar","filing":"0000875045-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000036/form4.xml","form_type":"4"}},{"id":817893,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:05:27.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":54,"price":183.78,"value":9924.12,"ownership":{"direct":true},"balance_after":1341.6667,"source":{"system":"sec-edgar","filing":"0000875045-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000036/form4.xml","form_type":"4"}},{"id":817892,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:05:27.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":181,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1395.6667,"source":{"system":"sec-edgar","filing":"0000875045-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000036/form4.xml","form_type":"4"}},{"id":903286,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:18:48.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":38015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":38015,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":38015},"source":{"system":"sec-edgar","filing":"0000875045-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000035/form4.xml","form_type":"4"}},{"id":903285,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:17:51.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":10560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":10560,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":10560},"source":{"system":"sec-edgar","filing":"0000875045-26-000034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000034/form4.xml","form_type":"4"}},{"id":903284,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:16:40.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":10560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":10560,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":10560},"source":{"system":"sec-edgar","filing":"0000875045-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000033/form4.xml","form_type":"4"}},{"id":903283,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-18T01:16:40.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":3,"price":195.035,"value":585.105,"ownership":{"direct":true},"balance_after":19611.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000033/form4.xml","form_type":"4"}},{"id":903282,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:14:49.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8450,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0000875045-26-000032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000032/form4.xml","form_type":"4"}},{"id":903281,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:12:09.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8025,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8025},"source":{"system":"sec-edgar","filing":"0000875045-26-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000031/form4.xml","form_type":"4"}},{"id":903280,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:11:16.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":7390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":7390,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":7390},"source":{"system":"sec-edgar","filing":"0000875045-26-000030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000030/form4.xml","form_type":"4"}},{"id":903279,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:10:17.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8450,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0000875045-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000029/form4.xml","form_type":"4"}},{"id":903278,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:09:09.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8025,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8025},"source":{"system":"sec-edgar","filing":"0000875045-26-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000028/form4.xml","form_type":"4"}},{"id":903277,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:07:57.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":1800,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0000875045-26-000027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000027/form4.xml","form_type":"4"}},{"id":903276,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:05:49.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8450,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0000875045-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000026/form4.xml","form_type":"4"}},{"id":913200,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":15453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":30907,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":15453},"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913199,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":9009,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":9008},"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913198,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":6624,"price":201.18,"value":1332616.32,"ownership":{"direct":true},"balance_after":29924,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913197,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":15453,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36548,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913196,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":4356,"price":201.18,"value":876340.08,"ownership":{"direct":true},"balance_after":21095,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913195,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":25327,"kind":"person","name":"Viehbacher Christopher","position":1,"cik":"0001774478","reported_name":"Viehbacher Christopher","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T22:06:49.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25451,"source":{"system":"sec-edgar","filing":"0000875045-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000024/form4.xml","form_type":"4"}},{"id":913194,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-06","kind":"exercise","planned":true,"acquired":false,"shares":4683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":9367,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":4683},"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913193,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-06","kind":"exercise","planned":true,"acquired":false,"shares":2217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":2217,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":2217},"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913192,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":2660,"price":199.83,"value":531547.8,"ownership":{"direct":true},"balance_after":8043.1428,"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913191,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-06","kind":"tax_withholding","planned":true,"acquired":false,"shares":1412,"price":201.18,"value":284066.16,"ownership":{"direct":true},"balance_after":10703.1428,"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913190,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-06","kind":"exercise","planned":true,"acquired":true,"shares":4683,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12115.1428,"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913189,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-06","kind":"tax_withholding","planned":true,"acquired":false,"shares":1056,"price":201.18,"value":212446.08,"ownership":{"direct":true},"balance_after":7432.1428,"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913188,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66329,"kind":"person","name":"Singhal Priya","position":1,"cik":"0001769608","reported_name":"Singhal Priya","relationship":{"officer":true,"officer_title":"Head of Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:05:47.000Z","date":"2026-02-06","kind":"exercise","planned":true,"acquired":true,"shares":2217,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8488.1428,"source":{"system":"sec-edgar","filing":"0000875045-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000023/form4.xml","form_type":"4"}},{"id":913178,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":4683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":9367,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":4683},"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913177,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1940,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1940},"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913176,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2102},"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913175,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1408,"price":201.18,"value":283261.44,"ownership":{"direct":true},"balance_after":19608.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913174,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":4683,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21016.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913173,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":201.18,"value":183878.52,"ownership":{"direct":true},"balance_after":16333.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913172,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17247.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913171,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1017,"price":201.18,"value":204600.06,"ownership":{"direct":true},"balance_after":15307.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913170,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025."}],"balance_after":16324.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913187,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":7024,"derivative":{"exercise_price":0,"expiration_date":"2025-02-06","underlying":"Common Stock","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913186,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":704,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":703},"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913185,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":789},"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913184,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1063,"price":201.18,"value":213854.34,"ownership":{"direct":true},"balance_after":11471.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913183,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12534.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913182,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":207,"price":201.18,"value":41644.26,"ownership":{"direct":true},"balance_after":9023.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913181,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9230.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913180,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":273,"price":201.18,"value":54922.14,"ownership":{"direct":true},"balance_after":8527.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913179,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":61588,"kind":"person","name":"Kramer Robin","position":1,"cik":"0001609222","reported_name":"Kramer Robin","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T22:02:17.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":789,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8800.7483,"source":{"system":"sec-edgar","filing":"0000875045-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000021/form4.xml","form_type":"4"}},{"id":913169,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:01:16.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":6557,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":3278},"source":{"system":"sec-edgar","filing":"0000875045-26-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000020/form4.xml","form_type":"4"}},{"id":913168,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:01:16.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1802,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1802},"source":{"system":"sec-edgar","filing":"0000875045-26-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000020/form4.xml","form_type":"4"}},{"id":913167,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:01:16.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":994,"price":201.18,"value":199972.92,"ownership":{"direct":true},"balance_after":5881,"source":{"system":"sec-edgar","filing":"0000875045-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000020/form4.xml","form_type":"4"}},{"id":913166,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:01:16.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3278,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6875,"source":{"system":"sec-edgar","filing":"0000875045-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000020/form4.xml","form_type":"4"}},{"id":913165,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:01:16.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":589,"price":201.18,"value":118495.02,"ownership":{"direct":true},"balance_after":3597,"source":{"system":"sec-edgar","filing":"0000875045-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000020/form4.xml","form_type":"4"}},{"id":913164,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":49770,"kind":"person","name":"Keeney Adam","position":1,"cik":"0001973607","reported_name":"Keeney Adam","relationship":{"officer":true,"officer_title":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2026-02-10T22:01:16.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4186,"source":{"system":"sec-edgar","filing":"0000875045-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000020/form4.xml","form_type":"4"}},{"id":913163,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":6087,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":3043},"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913162,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1802,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1802},"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913161,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2044},"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913160,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":775,"price":201.18,"value":155914.5,"ownership":{"direct":true},"balance_after":11011,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913159,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3043,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11786,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913158,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":201.18,"value":92140.44,"ownership":{"direct":true},"balance_after":8743,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913157,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9201,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913156,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":805,"price":201.18,"value":161949.9,"ownership":{"direct":true},"balance_after":7399,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913155,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66327,"kind":"person","name":"Izzar Rachid","position":1,"cik":"0001875506","reported_name":"Izzar Rachid","relationship":{"officer":true,"officer_title":"Head of Global Product Strat."}}],"security":"Common Stock","published_at":"2026-02-10T22:00:19.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order."}],"balance_after":8204,"source":{"system":"sec-edgar","filing":"0000875045-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000019/form4.xml","form_type":"4"}},{"id":913154,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:59:12.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":3747,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":1873},"source":{"system":"sec-edgar","filing":"0000875045-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000018/form4.xml","form_type":"4"}},{"id":913153,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:59:12.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1385,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1385},"source":{"system":"sec-edgar","filing":"0000875045-26-000018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000018/form4.xml","form_type":"4"}},{"id":913152,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Common Stock","published_at":"2026-02-10T21:59:12.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":584,"price":201.18,"value":117489.12,"ownership":{"direct":true},"balance_after":4058,"source":{"system":"sec-edgar","filing":"0000875045-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000018/form4.xml","form_type":"4"}},{"id":913151,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Common Stock","published_at":"2026-02-10T21:59:12.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1873,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4642,"source":{"system":"sec-edgar","filing":"0000875045-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000018/form4.xml","form_type":"4"}},{"id":913150,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Common Stock","published_at":"2026-02-10T21:59:12.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":407,"price":201.18,"value":81880.26,"ownership":{"direct":true},"balance_after":2769,"source":{"system":"sec-edgar","filing":"0000875045-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000018/form4.xml","form_type":"4"}},{"id":913149,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66326,"kind":"person","name":"Grogan Jane","position":1,"cik":"0001995547","reported_name":"Grogan Jane","relationship":{"officer":true,"officer_title":"Head of Research"}}],"security":"Common Stock","published_at":"2026-02-10T21:59:12.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3176,"source":{"system":"sec-edgar","filing":"0000875045-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000018/form4.xml","form_type":"4"}},{"id":913148,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":7494,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":3746},"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913147,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1802,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1802},"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913146,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":1635},"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913145,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1132,"price":201.18,"value":227735.76,"ownership":{"direct":true},"balance_after":22358.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913144,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23490.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913143,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":666,"price":201.18,"value":133985.88,"ownership":{"direct":true},"balance_after":19744.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913142,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20410.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913141,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":791,"price":201.18,"value":159133.38,"ownership":{"direct":true},"balance_after":18608.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913140,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025."}],"balance_after":19399.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913139,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:56:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/06/2025."}],"balance_after":1035,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":517},"source":{"system":"sec-edgar","filing":"0000875045-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000016/form4.xml","form_type":"4"}},{"id":913138,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:56:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/07/2024."}],"balance_after":305,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":305},"source":{"system":"sec-edgar","filing":"0000875045-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000016/form4.xml","form_type":"4"}},{"id":913137,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:56:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":257},"source":{"system":"sec-edgar","filing":"0000875045-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000016/form4.xml","form_type":"4"}},{"id":913136,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54040,"kind":"person","name":"Godbout Sean","position":1,"cik":"0002057736","reported_name":"Godbout Sean","relationship":{"officer":true,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:56:59.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":180,"price":201.18,"value":36212.4,"ownership":{"direct":true},"balance_after":1214.6667,"source":{"system":"sec-edgar","filing":"0000875045-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000016/form4.xml","form_type":"4"}}],"next_cursor":"2026-02-10T21:56:59.000000Z,913136"}